News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Interview Jul 19, 2024 Expanding the Alimentiv Site Network: An Interview With Peter Westerveld The Alimentiv Site Network (ASN) is our worldwide network of gastrointestinal (GI) centers that collaborate with us. With an established global reputation for high-quality monitoring… Read Now
Publication Jan 16, 2018 Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis Read Now
Publication Jan 11, 2018 Reliability of Measuring Ileo-Colonic Disease Activity in Crohn’s Disease by Magnetic Resonance Enterography Read Now
Publication Jan 11, 2018 Disease activity indices in coeliac disease: systematic review and recommendations for clinical trials Read Now
Publication Jan 5, 2018 The Expanding Therapeutic Armamentarium for Inflammatory Bowel Disease: How to Choose the Right Drug[s] for Our Patients? Read Now
Publication Nov 2, 2017 Centrally Determined Standardization of Flow Cytometry Methods Reduces Interlaboratory Variation in a Prospective Multicenter Study Read Now
Publication Oct 17, 2017 Systematic Review: Disease Activity Indices in Eosinophilic Esophagitis Read Now
